Influence of Limb Dominance on Parkinsonian Neurodegeneration in Rats: An Immunoblot Analysis Using the P+L Model

Advisor(s)

Dilshan Beligala

Confirmation

1

Document Type

Poster

Location

ONU McIntosh Center; Activities Room

Start Date

24-4-2026 10:00 AM

End Date

24-4-2026 10:50 AM

Abstract

Influence of Limb Dominance on Parkinsonian Neurodegeneration in Rats: An Immunoblot Analysis Using the P+L Model

Ethan Clarka, Dipesh Pokharelb,c, Kala Venkiteswaranb, c, d, Thyagarajan Subramanianb, c, d, Dilshan Beligalaa

aDepartment of Biological Sciences, Ohio Northern University, Ada, OH, USA

bDepartment of Neurosciences and Psychiatry, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

cDepartment of Neurology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

dDepartment of Neurology, Howard University, Washington, DC, USA

Hemispheric lateralization describes the distinct information-processing roles of the brain’s two hemispheres. Parkinson’s disease (PD) is a progressive neurodegenerative disorder marked by motor symptoms that are unilateral at onset in over 85% of patients. Despite this clear asymmetry, the role of hemispheric lateralization in PD progression remains poorly understood. Paw preference in rats, analogous to human handedness, provides a useful model to study lateralized brain function. This study examines whether paw preference influences hemispheric vulnerability in a paraquat and lectin (P+L) rodent model of PD. Specifically, it investigates whether limb dominance is associated with asymmetric dopaminergic degeneration and changes in protein expression. Immunoblotting is used to compare hemispheric expression of key dopaminergic markers: tyrosine hydroxylase (TH), dopa decarboxylase (DDC), and vesicular monoamine transporter 2 (VMAT2), across brain regions central to PD pathology, including the substantia nigra pars compacta (SNpc), dorsal striatum, ventral striatum, and ventral tegmental area. Our preliminary analyses in control animals show no significant hemispheric differences in these proteins, while data collection for P+L-treated animals is ongoing. Identifying hemispheric differences could help explain selective neuronal vulnerability and support the development of more targeted therapeutic strategies.

This document is currently not available here.

Restricted

Available to ONU community via local IP address and ONU login.

Share

COinS
 
Apr 24th, 10:00 AM Apr 24th, 10:50 AM

Influence of Limb Dominance on Parkinsonian Neurodegeneration in Rats: An Immunoblot Analysis Using the P+L Model

ONU McIntosh Center; Activities Room

Influence of Limb Dominance on Parkinsonian Neurodegeneration in Rats: An Immunoblot Analysis Using the P+L Model

Ethan Clarka, Dipesh Pokharelb,c, Kala Venkiteswaranb, c, d, Thyagarajan Subramanianb, c, d, Dilshan Beligalaa

aDepartment of Biological Sciences, Ohio Northern University, Ada, OH, USA

bDepartment of Neurosciences and Psychiatry, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

cDepartment of Neurology, The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

dDepartment of Neurology, Howard University, Washington, DC, USA

Hemispheric lateralization describes the distinct information-processing roles of the brain’s two hemispheres. Parkinson’s disease (PD) is a progressive neurodegenerative disorder marked by motor symptoms that are unilateral at onset in over 85% of patients. Despite this clear asymmetry, the role of hemispheric lateralization in PD progression remains poorly understood. Paw preference in rats, analogous to human handedness, provides a useful model to study lateralized brain function. This study examines whether paw preference influences hemispheric vulnerability in a paraquat and lectin (P+L) rodent model of PD. Specifically, it investigates whether limb dominance is associated with asymmetric dopaminergic degeneration and changes in protein expression. Immunoblotting is used to compare hemispheric expression of key dopaminergic markers: tyrosine hydroxylase (TH), dopa decarboxylase (DDC), and vesicular monoamine transporter 2 (VMAT2), across brain regions central to PD pathology, including the substantia nigra pars compacta (SNpc), dorsal striatum, ventral striatum, and ventral tegmental area. Our preliminary analyses in control animals show no significant hemispheric differences in these proteins, while data collection for P+L-treated animals is ongoing. Identifying hemispheric differences could help explain selective neuronal vulnerability and support the development of more targeted therapeutic strategies.